Business

April 3, 2014 9:28 AM

Scynexis lowers IPO expectations

Drug-development company Scynexis plans to sell its shares at a significantly lower price than previously anticipated in order to make its initial public offering of stock happen.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs